| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Dorsey Brian is a Chief Operating Officer at ARS Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $315K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | SPRY Ars Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 21,828 | $8.71 | $190,049.85 | -66.9% | +13.0% | - | |
| Dec 12, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 40,000 | $12.35 | $493,858.50 | -76.9% | -2.6% | -19.0% | |
| Aug 20, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 50,000 | $15.00 | $750,000.00 | -89.2% | -7.5% | -1.9% | |
| Aug 13, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Operating Officer | Sale+OE | 30,000 | $13.00 | $390,000.00 | -83.3% | +33.9% | +21.1% |